Dacron or PTFE for Above-knee Femoropopliteal Bypass. A Multicenter Randomised Study

Abstract

This trial confirms that Dacron is at least as durable as PTFE for above-knee bypass procedures, and might even be superior.

Trends and outcomes after surgical lower limb revascularization in England

“…The in‐hospital mortality rate of 6·7 per cent after femoropopliteal bypass was comparatively high despite a significant reduction over the 5 years. Perioperative rates of between 0 and 7 per cent have been published internationally18, 19, but the most comparable data are from the UK BASIL trial which reported a 30‐day mortality rate of 5·6 per cent. This suggests that the rate reported in the present population analysis was valid, but it was high compared with rates in other developed countries.…”

Analysis of risk factors for occlusions of a synthetic femoropopliteal bypass graft

“…If the great saphenous vein is not available Dacron has a small patency benefit if compared to PTFE in above-knee FP reconstruction 19,20 and PTFE graft is an alternative to a belowknee FP bypass 4, 21 . We used a Dacron graft for above-knee and PTFE graft for below-knee FP bypass.…”

Surgical treatment of lower limb ischemia in diabetic patients – long-term results

“…These procedures constituted 19% of all bypass procedures and were the cause of 62% of all graft thromboses (Table IV). The 2-year primary patency rate for above-knee femoropopliteal bypass with PTFE graft was reported as 57%, 55%, and 54% in different series [14–17]. Consequently, above-knee femoropopliteal bypasses with ePTFE grafts were not related to high patency rates.…”